Grassley to hold drug pricing hearing

Grassley to hold drug pricing hearing
© Stefani Reynolds

The Senate Finance Committee's first hearing of the year will focus on prescription drug prices, panel chairman Sen. Chuck GrassleyCharles (Chuck) Ernest GrassleyTrump administration to impose tariffs on French products in response to digital tax Big Ten moves to conference-only model for all fall sports Republicans considering an outdoor stadium for Florida convention: report MORE (R-Iowa) announced Tuesday.

The Jan. 29 hearing "will be the first in a series of hearings scrutinizing prescription drug pricing and considering policy and oversight solutions to lower costs for American patients," Grassley said in a statement Tuesday.

"We already know what the problem is. It’s time to look at bipartisan solutions and work to turn them into law,” he added.

The Senate hearing will be the same day the Democratic-led House Oversight and Reform Committee holds the first of its own drug pricing hearings.

ADVERTISEMENT

The two hearings on the same day shows the bipartisan nature of the concern over rising drug prices.

Grassley and House Oversight and Reform Committee Chairman Elijah CummingsElijah Eugene CummingsFacial recognition tools under fresh scrutiny amid police protests The sad spectacle of Trump's enablers Democrat Kweisi Mfume wins House primary in Maryland MORE (D-Md.) have made rising drug prices a central concern.

Grassley is largely seen as a dogged investigator who backs free-market principles, and is not seen as an ally of the pharmaceutical industry.

He is also willing to work with Democrats. In September he teamed up with Sen. Dick DurbinRichard (Dick) Joseph DurbinThe Hill's Morning Report - Presented by Argentum - All eyes on Florida as daily COVID-19 cases hit 15K Democrats see immigration reform as topping Biden agenda GOP senators voice confidence over uphill Senate battle MORE (D-Ill.) to legislate that television advertisements for drugs be accompanied by price disclosures. The measure was ultimately blocked by House Republicans.

Earlier this month, Grassley laid out his priorities for drug pricing action, including legislation with Sen. Amy KlobucharAmy KlobucharThe Hill's Coronavirus Report: Fauci says focus should be on pausing reopenings rather than reverting to shutdowns; WHO director pleads for international unity in pandemic response State election officials warn budget cuts could lead to November chaos Biden strikes populist tone in blistering rebuke of Trump, Wall Street MORE (D-Minn.) that would allow patients to import prescription drugs from Canada.

He has also expressed support for much of President TrumpDonald John TrumpIvanka Trump pitches Goya Foods products on Twitter Sessions defends recusal: 'I leave elected office with my integrity intact' Former White House physician Ronny Jackson wins Texas runoff MORE's drug pricing agenda.